Certain positive regulatory factors, such as CD27, CD28, CD30, ICOS, and negative regulatory factors, such as CTLA4, PD-1, BTLA, TIM3, andLAG3, at immune checkpoints affect the recognition and apoptotic ability of the immune system against tumour cells [39–41]. The gene discussed is BTLA; the disease is neoplasm.